Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs)

NCT: NCT05741866 · COMPLETED

NCT IDNCT05741866
StatusCOMPLETED
Start Date2023-05-03
Completion2024-06-03

Brief Summary

The goal of this clinical trial is to compare a chlorhexidine impregnated dressing for peripheral intravenous catheters (PIVCs) to the standard dressing currently used in general medical and surgical inpatient wards. The main questions it aims to answer are: * Study Feasibility * Occurrence of infectious complications related to the PIVC Participants will be randomly allocated to receive either of the below dressings to cover and secure their PIVC: * The standard dressing used at their hospital, or * The intervention dressing which has Chlorhexidine gluconate (CHG) on it Researchers will compare standard and CHG dressings to see if the presence of CHG improves the occurrence of infectious complications related to the PIVC.

Frequently Asked Questions

What is Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs)?

Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs) is a clinical trial registered under NCT05741866. Current status: COMPLETED.

What is the status of NCT05741866?

The current status of NCT05741866 (Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs)) is: COMPLETED.

When did Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs) start?

Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs) started on 2023-05-03.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.